Table 3.
Top Ten Drugs Used in the US by Volume and Associated Savings with Federal Supply Schedule
| Prescription drug | Annual # prescriptions (weighted) | Current expenditures, Medical Expenditure Panel Survey* | Absolute savings with Federal Supply Schedule prices * | Percentage of current expenditure saved* |
|---|---|---|---|---|
| Atorvastatin (Lipitor) | 39,604,209 | $4,503,599,518 | $1,321,679,381 | 29.3% |
| Furosemide | 25,436,137 | 285,571,827 | 263,271,595 | 92.2% |
| Lisinopril | 23,265,084 | 1,164,407,869 | 1,061,399,316 | 91.2% |
| Hydrochlorothiazide | 22,127,830 | 210,155,282 | 182,224,109 | 86.7% |
| Atenolol | 21,679,039 | 993,571,279 | 945,249,018 | 95.1% |
| Amlodipine (Norvasc) | 19,960,498 | 1,493,847,690 | 456,753,328 | 30.6% |
| Levothyroxine (Synthroid) | 19,666,947 | 523,465,215 | 443,815,117 | 84.8% |
| Simvastatin (Zocor) | 19,224,615 | 2,358,898,147 | 662,973,114 | 28.1% |
| Metoprolol SR (Toprol XL) | 15,998,237 | 840,934,795 | 169,061,035 | 20.1% |
| Clopidogrel (Plavix) | 13,132,527 | 1,753,964,659 | 390,588,927 | 22.3% |
*All amounts are calculated in 2006 dollars